Kumar et al. [116] found that the oral supplementation of ellagic acid caused the transcriptional inactivation of ODC expression, reducing ACF proliferation and/or progression, thereby exhibiting the chemopreventive efficacy of EA against CRC. This evidence concerns the gene ODC1 and colorectal carcinoma.